Beranda › Karsinoma Epitel Ovarium › Texas › Houston
Uji klinis Karsinoma Epitel Ovarium di Houston, TX
6 studi untuk Karsinoma Epitel Ovarium mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Menerima pesertaFase 2
- Houston Methodist Hospital /ID# 274568, Houston
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Menerima pesertaFase 1
- Site 0103, Houston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Menerima pesertaFase 1/2
- MD Anderson Cancer Center, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
Menerima pesertaFase 1
- MD Anderson Cancer Center, Houston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Menerima pesertaFase 1
- MD Anderson Cancer Center, Houston
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Menerima pesertaFase 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Uji klinis Karsinoma Epitel Ovarium di kota lain
- Durham, NC8 studi
- Boston, MA8 studi
- New York City, NY7 studi
- San Diego, CA7 studi
- Chicago, IL7 studi
- Baltimore, MD6 studi
- Philadelphia, PA6 studi
- Cleveland, OH6 studi
- Minneapolis, MN5 studi
- Salt Lake City, UT5 studi
- Portland, OR5 studi
- Edison, NJ5 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.